BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, BioLife Solutions's Total Revenue Growth Rate (Future 3Y To 5Y Est) is -0.70.
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.
BioLife Solutions (NAS:BLFS) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Thank you for viewing the detailed overview of BioLife Solutions's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.
Geraint Phillips | officer: SVP, Global Operations | 3303 MONTE VILLA, #310, BOTHELL WA 98021 |
Sarah Aebersold | officer: VP, Global Human Resources | BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Troy Wichterman | officer: Chief Financial Officer | 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Greef Roderick De | director | |
Aby J. Mathew | officer: Chief Tech. Officer & Sr. VP | 3303 MONTE VILLA PARKWAY, #310, BOTHELL WA 98021 |
Todd Berard | officer: Vice President, Marketing | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Karen A. Foster | officer: Vice President of Operations | C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Michael Rice | director, officer: President & CEO | C/O BIOLIFE SOLUTIONS, INC., 171 FRONT STREET, OWEGO NY 13827 |
Casdin Partners Master Fund, L.p. | 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Garrie Richardson | officer: Chief Revenue Officer | 3303 MONTE VILA PARKWAY, BOTHELL WA 98021 |
Marcus Schulz | officer: Vice President, Global Sales | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Joseph C Schick | director | 16719 NE 139TH PLACE, WOODINVILLE WA 98072 |
Amy Duross | director | 8410 GOLDEN BEAR PLACE, WHISTLER A1 V8E 1J7 |
Timothy L. Moore | director | C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404 |
Joydeep Goswami | director | SUMITOMO FUDOSAN MITA TWIN BLDG, EAST WING 4-2-8 SHIBAURA MINATO-KU, TOKYO M0 1080023 |
From GuruFocus
By PRNewswire PRNewswire • 06-19-2022
By PRNewswire PRNewswire • 06-09-2022
By PRNewswire PRNewswire • 08-02-2022
By GuruFocus Research • 05-27-2023
By PRNewswire PRNewswire • 11-17-2022
By GuruFocus Research GuruFocus Editor • 12-01-2022
By GuruFocus Research • 05-26-2023
By PRNewswire PRNewswire • 05-02-2023
By GuruFocus Research GuruFocus Editor • 05-18-2023
By PRNewswire PRNewswire • 11-21-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.